Oral Anticoagulation Therapy and Progression of Calcific Aortic Valve Stenosis

被引：21
|
作者：
Tastet, Lionel [1 ]
Pibarot, Philippe [1 ]
Shen, Mylene [1 ]
Clisson, Marine [1 ]
Cote, Nancy [1 ]
Salaun, Erwan [1 ]
Arsenault, Marie [1 ]
Bedard, Elisabeth [1 ]
Capoulade, Romain [1 ]
Puri, Rishi [1 ]
Poirier, Paul [1 ]
Clavel, Marie-Annick [1 ]
机构：
[1] Inst Univ Cardiol & Pneumol Quebec, 2725 Chemin St Foy, Quebec City, PQ G1V 4G5, Canada
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 73卷 / 14期
基金：
加拿大健康研究院;
关键词：
D O I：
10.1016/j.jacc.2019.01.043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1869 / 1871
页数：4
相关论文
共 50 条
  • [1] Oral Anticoagulation Therapy and Progression of Calcific Aortic Valve Stenosis: Factor Xa versus Factor IIa Inhibition?
    Dannenberg, Lisa
    Zako, Saif
    Mourikis, Philipp
    Veulemans, Verena
    Kelm, Malte
    Zeus, Tobias
    Polzin, Amin
    PHARMACOLOGY, 2019, 104 (3-4) : 212 - 213
  • [2] Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression
    Arsenault, Benoit J.
    Loganath, Krithika
    Girard, Arnaud
    Botezatu, Simona
    Zheng, Kang H.
    Tzolos, Evangelos
    Abdoun, Kathia
    Tastet, Lionel
    Capoulade, Romain
    Cote, Nancy
    Craig, Neil
    Chan, Kwan L.
    Tam, James W.
    Teo, Koon K.
    Couture, Christian
    Clavel, Marie-Annick
    Mathieu, Patrick
    Theriault, Sebastien
    Stroes, Erik S. G.
    Newby, David E.
    Tsimikas, Sotirios
    Pibarot, Philippe
    Dweck, Marc R.
    JAMA CARDIOLOGY, 2024, 9 (09) : 835 - 842
  • [3] Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis
    Capoulade, Romain
    Chan, Kwan L.
    Yeang, Calvin
    Mathieu, Patrick
    Bosse, Yohan
    Dumesnil, Jean G.
    Tam, James W.
    Teo, Koon K.
    Mahmut, Ablajan
    Yang, Xiaohong
    Witztum, Joseph L.
    Arsenault, Benoit J.
    Despres, Jean-Pierre
    Pibarot, Philippe
    Tsimikas, Sotirios
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (11) : 1236 - 1246
  • [4] Targeted therapy to prevent progression of calcific aortic stenosis
    Rajamannan, NM
    Otto, CM
    CIRCULATION, 2004, 110 (10) : 1180 - 1182
  • [5] Progression of Calcific Aortic Valve Sclerosis in WHHL Rabbits, an Animal Model of Aortic Valve Stenosis
    Hara, Tetsuya
    Tsukada, Norie
    Ishida, Tatsuro
    Hirata, Ken-ichi
    Shiomi, Masashi
    CIRCULATION, 2017, 136
  • [6] Impact of genotype on the progression of calcific aortic valve stenosis (prospective study)
    Boeva, O. I.
    Shcheglova, E. V.
    Yagoda, A. V.
    Khayt, G. Y.
    Chotchaeva, Z. C. H.
    Baikulova, M. K. H.
    Laipanova, A. I.
    EUROPEAN HEART JOURNAL, 2016, 37 : 557 - 557
  • [7] Bone Mineral Density and Progression Rate of Calcific Aortic Valve Stenosis
    Tastet, Lionel
    Shen, Mylene
    Capoulade, Romain
    Arsenault, Marie
    Bedard, Elisabeth
    Cote, Nancy
    Clavel, Marie-Annick
    Pibarot, Philippe
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (14) : 1725 - 1726
  • [8] Influence of metabolic syndrome and diabetes on progression of calcific aortic valve stenosis
    Testuz, Ariane
    Nguyen, Virginia
    Mathieu, Tiffany
    Kerneis, Caroline
    Arangalage, Dimitri
    Kubota, Naozumi
    Codogno, Isabelle
    Tubiana, Sarah
    Estellat, Candice
    Cimadevilla, Claire
    Vahanian, Alec
    Messika-Zeitoun, David
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 244 : 248 - 253
  • [9] Translocation of aortic valve for calcific aortic stenosis
    Ninomiya M.
    Makuuchi H.
    Naruse Y.
    Kobayashi T.
    Sato T.
    The Japanese Journal of Thoracic and Cardiovascular Surgery, 2000, 48 (1): : 83 - 85
  • [10] Histopathology of calcific aortic valve stenosis
    Somers, Pamela
    Knaapen, Michiel
    Mistiaen, Wilhelm
    ACTA CARDIOLOGICA, 2006, 61 (05) : 557 - 562
12345